A clinical-stage biotechnology company developing intranasal therapies and vaccines, with a focus on treatments for neurological conditions and infectious diseases. Its lead programs include intranasal drug candidates designed to deliver therapeutics directly to the brain and central nervous system....
No congressional trades have been disclosed for Oragenics, Inc. (OGEN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.